Hackensack Meridian Health Studying the Blood of COVID-19 Survivors
April 30, 2020
Researchers and clinical experts at Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, are looking into the blood of COVID-19 survivors, as a potential treatment for current COVID-19 patients.
The work will scrutinize the antibodies within the serum of the surviving patients, in an attempt to discover more about the disease, and perhaps develop new ways to fight it.
“I’m so proud of our robust and innovative response to this unprecedented global challenge, from our front-line care teams to our support staff, and our exceptional researchers,” said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health. “Our scientists have been at the forefront of the latest innovations, including developing our own test and taking part in clinical trials of antiviral drugs. Now they’re taking a leadership role in this advanced antibody work, which could prove to be a breakthrough.”